Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBristol-Myers Squibb Co. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 17 | $1.33 | $1.51 | $1.42 |
| Q2 2026 | 15 | $1.53 | $1.62 | $1.60 |
| Q3 2026 | 14 | $1.63 | $1.80 | $1.72 |
| Q4 2026 | 13 | $1.50 | $1.67 | $1.59 |
| Q1 2027 | 5 | $1.38 | $1.49 | $1.45 |
| Q2 2027 | 5 | $1.57 | $1.70 | $1.65 |
| Q3 2027 | 5 | $1.45 | $1.57 | $1.53 |
| Q4 2027 | 5 | $1.52 | $1.65 | $1.60 |
| Q1 2028 | 6 | $1.16 | $1.25 | $1.22 |
| Q2 2028 | 6 | $1.34 | $1.46 | $1.41 |
| Q3 2028 | 6 | $1.25 | $1.35 | $1.31 |
| Q4 2028 | 7 | $1.34 | $1.45 | $1.41 |
Bristol-Myers Squibb Co. Earnings Date And Information
Bristol-Myers Squibb Co. last posted its earnings results on Thursday, July 30th, 2026. The company reported $2.04 earnings per share for the quarter, topping analysts' consensus estimates of $1.6 by $0.44. The company had revenue of 12.97 B for the quarter and had revenue of 48.20 B for the year. Bristol-Myers Squibb Co. has generated $3 earnings per share over the last year ($3.45 diluted earnings per share) and currently has a price-to-earnings ratio of 14.76. Bristol-Myers Squibb Co. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Bristol-Myers Squibb Co. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/30/2026 | Q2 2026 | $1.60 | $1.62 | 0.02 | $11.74 B | $12.97 B |
| 04/30/2026 | Q1 2026 | $1.42 | $1.31 | -0.11 | $10.93 B | $11.49 B |
| 02/11/2026 | Q4 2025 | N/A | $0.53 | N/A | $12.28 B | $12.50 B |
| 10/30/2025 | Q3 2025 | $1.52 | $1.08 | -0.44 | $11.85 B | $12.22 B |
| 07/31/2025 | Q2 2025 | $1.09 | $0.64 | -0.45 | $11.44 B | $12.27 B |
| 04/24/2025 | Q1 2025 | $1.49 | $1.21 | -0.28 | $10.70 B | $11.20 B |
| 02/12/2025 | Q4 2024 | N/A | $0.04 | N/A | $11.57 B | $12.34 B |
| 10/31/2024 | Q3 2024 | $1.49 | $0.60 | -0.89 | $11.26 B | $11.89 B |
| 07/26/2024 | Q2 2024 | $1.62 | $0.83 | -0.79 | $11.54 B | $12.20 B |
| 04/25/2024 | Q1 2024 | -$4.41 | -$5.89 | -1.48 | $11.48 B | $11.87 B |
| 02/13/2024 | Q4 2023 | N/A | $0.87 | N/A | $11.19 B | $11.48 B |
| 10/26/2023 | Q3 2023 | $1.76 | $0.94 | -0.82 | $10.96 B | $10.97 B |
| 07/27/2023 | Q2 2023 | $1.99 | $0.99 | -1 | $11.77 B | $11.23 B |
| 04/27/2023 | Q1 2023 | $1.98 | $1.08 | -0.9 | $11.50 B | $11.34 B |
| 02/14/2023 | Q4 2022 | N/A | $0.96 | N/A | $11.19 B | $11.41 B |
| 10/26/2022 | Q3 2022 | N/A | $0.75 | N/A | $11.14 B | $11.22 B |
| 07/27/2022 | Q2 2022 | $1.79 | $0.67 | -1.12 | $11.42 B | $11.89 B |
| 04/29/2022 | Q1 2022 | $1.92 | $0.60 | -1.32 | $11.36 B | $11.65 B |
| 02/09/2022 | Q4 2021 | N/A | $1.10 | N/A | $12.04 B | $11.99 B |
| 10/27/2021 | Q3 2021 | $1.91 | $0.70 | -1.21 | $11.61 B | $11.62 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bristol-Myers Squibb Co. Earnings: FAQ's
In the previous quarter, Bristol-Myers Squibb Co. (:BMY) reported $2.04 earnings per share (EPS) to beat the analysts' consensus estimate of $1.6 by $0.44.
The conference call for Bristol-Myers Squibb Co.'s latest earnings report can be listened to online.
The conference call transcript for Bristol-Myers Squibb Co.'s latest earnings report can be read online.
Bristol-Myers Squibb Co. (:BMY) has a recorded annual revenue of $48.20 B.
Bristol-Myers Squibb Co. (:BMY) has a recorded net income of $7.05 B.Bristol-Myers Squibb Co. has generated $3.46 earnings per share over the last four quarters.
Bristol-Myers Squibb Co. (:BMY) has a price-to-earnings ratio of 14.76 and price/earnings-to-growth ratio is 0.18.